Literature DB >> 8021247

Endoproteolytic processing of proopiomelanocortin and prohormone convertases 1 and 2 in neuroendocrine cells overexpressing prohormone convertases 1 or 2.

A Zhou1, R E Mains.   

Abstract

AtT-20 mouse corticotrope tumor cell lines overexpressing the prohormone convertases PC1 or PC2 were established and used to examine prohormone and prohormone convertase biosynthetic processing. On a molar basis, wild-type AtT-20 cells synthesize about 20% as much PC1 as the endogenous prohormone, proopiomelanocortin (POMC). Kinetic, oligosaccharide, and temperature blockade analyses established that proPC1 is converted to PC1 in the endoplasmic reticulum at a rate independent of the level of PC1 or PC2 expression. In contrast, proPC2 is converted to PC2 primarily in a post-trans-Golgi compartment. PC1 is further shortened from its COOH-terminal end in a post-trans-Golgi compartment in a step that is accelerated at higher levels of PC1 expression, but unaltered by PC2 overexpression. The initial steps in POMC processing are speeded up by overexpression of PC1, and overexpression of PC1 leads to more extensive cleavage of POMC to smaller products. However, even when the rate of PC1 synthesis exceeds that for POMC by 2-fold, PC1 does not cleave the Lys-Lys or Arg-Lys bonds cleaved upon overexpression of PC2.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8021247

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  47 in total

1.  Reprint of: Chromogranin A: a new proposal for trafficking, processing and induction of granule biogenesis.

Authors:  Hisatsugu Koshimizu; Taeyoon Kim; Niamh X Cawley; Y Peng Loh
Journal:  Regul Pept       Date:  2010-10-13

2.  Chromogranin A processing and secretion: specific role of endogenous and exogenous prohormone convertases in the regulated secretory pathway.

Authors:  N L Eskeland; A Zhou; T Q Dinh; H Wu; R J Parmer; R E Mains; D T O'Connor
Journal:  J Clin Invest       Date:  1996-07-01       Impact factor: 14.808

Review 3.  Neuropeptide-processing enzymes: applications for drug discovery.

Authors:  Lloyd D Fricker
Journal:  AAPS J       Date:  2005-10-05       Impact factor: 4.009

Review 4.  Neuroendocrine secretory protein 7B2: structure, expression and functions.

Authors:  M Mbikay; N G Seidah; M Chrétien
Journal:  Biochem J       Date:  2001-07-15       Impact factor: 3.857

5.  Dynamic modulation of prohormone convertase 2 (PC2)-mediated precursor processing by 7B2 protein: preferential effect on glucagon synthesis.

Authors:  Michael Helwig; Sang-Nam Lee; Jae Ryoung Hwang; Akihiko Ozawa; Juan F Medrano; Iris Lindberg
Journal:  J Biol Chem       Date:  2011-10-19       Impact factor: 5.157

6.  7B2 prevents unfolding and aggregation of prohormone convertase 2.

Authors:  Sang-Nam Lee; Iris Lindberg
Journal:  Endocrinology       Date:  2008-05-08       Impact factor: 4.736

7.  Synthetic small-molecule prohormone convertase 2 inhibitors.

Authors:  Dorota Kowalska; Jin Liu; Jon R Appel; Akihiko Ozawa; Adel Nefzi; Robert B Mackin; Richard A Houghten; Iris Lindberg
Journal:  Mol Pharmacol       Date:  2008-12-12       Impact factor: 4.436

Review 8.  Chromogranin A: a new proposal for trafficking, processing and induction of granule biogenesis.

Authors:  Hisatsugu Koshimizu; Taeyoon Kim; Niamh X Cawley; Y Peng Loh
Journal:  Regul Pept       Date:  2009-12-16

9.  Biochemical and cell biological properties of the human prohormone convertase 1/3 Ser357Gly mutation: a PC1/3 hypermorph.

Authors:  Elias H Blanco; Juan R Peinado; Martín G Martín; Iris Lindberg
Journal:  Endocrinology       Date:  2014-06-16       Impact factor: 4.736

10.  Internal cleavage of the inhibitory 7B2 carboxyl-terminal peptide by PC2: a potential mechanism for its inactivation.

Authors:  X Zhu; Y Rouille; N S Lamango; D F Steiner; I Lindberg
Journal:  Proc Natl Acad Sci U S A       Date:  1996-05-14       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.